The pivotal clinical trial of Biogen’s intramuscular interferon beta-1a (IFN β-1a; AVONEX®) was being conducted when IFN β-1b (Betaseron®, Bayer, Germany) was approved in 1993 as the first ...

The randomized, placebo-controlled CHAMPS trial found early treatment with interferon -1a to be beneficial (Journal Watch Neurology Nov 2 2000); in this substudy, researchers analyzed data on ...

Objective: To evaluate the cost effectiveness of subcutaneous interferon-ß-1a (IFNß-1a) 44µg three times weekly in relapsing-remitting multiple sclerosis (RRMS) using an econometric model.

The inhaled formulation of interferon beta-1a – delivered using a nebuliser – will be tested in 610 hospitalised COVID-19 patients who require supplemental oxygen in around 20 countries in the ...

Rebif (interferon beta-1a) is a prescription drug used to treat some types of multiple sclerosis (MS). Rebif may be safe to use while pregnant or breastfeeding. Keep ...

UK biotech Synairgen has started dosing patients in its phase 2 trial of SNG001, an inhaled formulation of interferon beta-1a that aims to treat coronavirus infections. The drug is already widely ...